MLchartDataset catalogue

Allogeneic large multivalent immunogen melanoma vaccine LP2307

Term · Oncology and biomedicine · MLC-T-ONC-009916

A cancer vaccine, containing human-specific large multivalent immunogen (LMI) isolated from plasma membrane fractions of the melanoma cell lines MSM-M1 and MSM-M2, with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen melanoma vaccine LP2307 may stimulate a CD8+ cytotoxic T lymphocyte (CTL) response against melanoma tumor cells that express melanoma-specific LMI.

Table 1. Record
IdentifierMLC-T-ONC-009916
FieldOncology and biomedicine
Synonymsallogeneic LMI melanoma vaccine LP2307
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009916",
  "term": "Allogeneic large multivalent immunogen melanoma vaccine LP2307",
  "field": "Oncology and biomedicine",
  "definition": "A cancer vaccine, containing human-specific large multivalent immunogen (LMI) isolated from plasma membrane fractions of the melanoma cell lines MSM-M1 and MSM-M2, with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic large multivalent immunogen melanoma vaccine LP2307 may stimulate a CD8+ cytotoxic T lymphocyte (CTL) response against melanoma tumor cells that express melanoma-specific LMI.",
  "synonyms": [
    "allogeneic LMI melanoma vaccine LP2307"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/allogeneic-large-multivalent-immunogen-melanoma-vaccine-lp2307/"
}

Record 802 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.